Shareholding disclosure

Basilea Pharmaceutica Ltd

Declared position

34.03%

Threshold

Crossed downwards

Timeline

Published

28.04.2021

Transaction

21.04.2021

Voting rights breakdown

Voting rights acquired9.35%

Voting rights sold34.03%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL4Q00049

Beneficial owner

Basilea Pharmaceutica Ltd

Declared address

Basilea Pharmaceutica Ltd., 4058 Basel

Granting of Restricted Share Units and Performance Share Units

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica Ltd

Basilea Pharmaceutica AG, Allschwil28.04.2021TAL4Q00049

Disclosure summary

Basilea Pharmaceutica Ltd disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 28.04.2021, at 34.03% of voting rights. Notice category: Single shareholder.

Disclosed position

34.03%

Voting rights sold

Voting rights acquired9.35%

Voting rights sold34.03%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica Ltd disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 28.04.2021.

Publication date28.04.2021

Transaction date21.04.2021

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica Ltd

Declared addressBasilea Pharmaceutica Ltd., 4058 Basel

CategorySingle shareholder

Voting rights acquired9.35%

Voting rights sold34.03%

Below threshold0%

ExchangeXSWX

Notification IDTAL4Q00049

Conditions

Granting of Restricted Share Units and Performance Share Units

Source: SIX Exchange Regulation · Publication date: 28.04.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open